Biomarin Pharmaceutical (BMRN) EBITDA Margin (2009 - 2026)
Biomarin Pharmaceutical (BMRN) reported EBITDA Margin of 21.07% for Q2 2026, down 14.72 percentage points from 35.79% a year earlier but up 2.01 percentage points from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's EBITDA Margin came in at 8.87%, down 19.18 percentage points year-over-year; for FY2025, it was 15.18%, down 5.16 percentage points from FY2024.
- EBITDA Margin has a five-year change of +11.86 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 20.35% in FY2024 (+8.35 pp), 11.99% in FY2023 (-0.55 pp), 12.54% in FY2022 (+11.15 pp) and 1.39% in FY2021 (-1.93 pp).
- Five-year quarterly EBITDA Margin spans a low of -8.87% in Q4 2021 and a high of 35.79% in Q2 2025.
- Year over year, EBITDA Margin has now declined in each of the last four quarters, with an average year-over-year change of -2.85 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q1 2022 (a gain of 20.79 percentage points); the low point was Q4 2025 (a drop of 27.52 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 19.06% (Q1 2026), -2.76% (Q4 2025) and -3.63% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 21.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.07% |
| Mar 31, 2026 | 19.06% |
| Dec 31, 2025 | -2.76% |
| Sep 30, 2025 | -3.63% |
| Jun 30, 2025 | 35.79% |
| Mar 31, 2025 | 33.01% |
| Dec 31, 2024 | 24.76% |
| Sep 30, 2024 | 17.82% |
| Jun 30, 2024 | 20.63% |
| Mar 31, 2024 | 17.85% |
| Dec 31, 2023 | 8.38% |
| Sep 30, 2023 | 9.67% |
| Jun 30, 2023 | 15.28% |
| Mar 31, 2023 | 14.89% |
| Dec 31, 2022 | 2.13% |
| Sep 30, 2022 | 4.43% |
| Jun 30, 2022 | 12.07% |
| Mar 31, 2022 | 31.71% |
| Dec 31, 2021 | -8.87% |
| Sep 30, 2021 | -6.45% |
API Access
Biomarin Pharmaceutical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();